ロード中...
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae
Background. Bloodstream infections (BSIs) due to ESBL-producing Enterobacteriaceae (ESBL-E) are frequent yet outcome prediction rules for clinical use have not been developed. The objective was to define and validate a predictive risk score for 30 day mortality. Methods. A multinational retrospectiv...
保存先:
| 出版年: | J Antimicrob Chemother |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5890678/ https://ncbi.nlm.nih.gov/pubmed/28062685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw513 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|